Leonard Rickey Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$570K Buy
1,474
+11
+0.8% +$4.08K 0.09% 66
2026
Q1
$428K Buy
1,463
+30
+2% +$9.86K 0.07% 73
2025
Q4
$502K Buy
1,433
+74
+5% +$25K 0.09% 69
2025
Q3
$439K Buy
1,359
+92
+7% +$28.6K 0.08% 75
2025
Q2
$493K Buy
1,267
+82
+7% +$33K 0.1% 62
2025
Q1
$523K Buy
1,185
+124
+12% +$49.8K 0.11% 57
2024
Q4
$391K Buy
1,061
+35
+3% +$14.6K 0.09% 66
2024
Q3
$534K Buy
1,026
+11
+1% +$5.88K 0.12% 60
2024
Q2
$550K Buy
1,015
+160
+19% +$84.6K 0.13% 56
2024
Q1
$443K Buy
855
+83
+11% +$41.3K 0.11% 55
2023
Q4
$364K Buy
772
+7
+0.9% +$3.24K 0.11% 57
2023
Q3
$333K Buy
+765
New +$347K 0.11% 56

Other funds holding ELV

Leonard Rickey Investment Advisors's ELV Position: Q2 2026 in Review

Leonard Rickey Investment Advisors increased its Elevance Health (ELV) stake by 0.75% in Q2 2026, buying an estimated $4.08K and bringing the position to 1,474 shares worth $570K. The position accounts for 0.09% of the portfolio, ranked #66.

Leonard Rickey Investment Advisors first reported a position in ELV in Q3 2023 and has held it in 12 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Leonard Rickey Investment Advisors held 1,474 shares of Elevance Health worth $570K as of Q2 2026.
  • Leonard Rickey Investment Advisors bought 11 Elevance Health shares in Q2 2026, an estimated $4.08K.
  • Elevance Health made up 0.09% of Leonard Rickey Investment Advisors's portfolio in Q2 2026, its #66 holding.
  • Leonard Rickey Investment Advisors first reported a position in Elevance Health in Q3 2023 and has held it in 12 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Leonard Rickey Investment Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.